Full Text View
Tabular View
No Study Results Posted
Related Studies
Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
This study is currently recruiting participants.
Verified February 2013 by The University of Texas, Galveston
Study NCT01573754   Information provided by The University of Texas, Galveston

First Received on April 5, 2012.   Last Updated on February 20, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Porphyria Cutanea Tarda
Additional conditions recognized in this trial
Porphyria, Erythropoietic
Porphyrias
Porphyrias, Hepatic
More general conditions related to this trial
Digestive System Diseases
Genetic Diseases, Inborn
Liver Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Skin Diseases
Skin Diseases, Genetic
Skin Diseases, Metabolic
Interventions listed in this trial
Hydroxychloroquine
Phlebotomy
More general drug interventions related to this trial
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
The University of Texas, Galveston


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services